Ciprofibrate works as a lipid-lowering agent, with side effects such as headache and fatigue. The medication should be used in accordance with medical advice. Ciprofibrate can inhibit hepatic cholesterol synthesis, lower blood cholesterol and triglycerides, and raise the protective HDL cholesterol protein cholesterol, and is indicated for the treatment of endogenous hypercholesterolemia and hypertriglyceridemia in adults. Side effects such as headache, fatigue, nausea, rash, and elevated aminotransferases may occur with use of the drug. Ciprofibrate is contraindicated in severe hepatic and renal impairment, primary biliary cirrhosis, hypoproteinemia, gallbladder lesions, nephrotic syndrome, pregnant and lactating women. People with hyperlipidemia need to use the drug under the evaluation and guidance of physicians. After using the drug, pay attention to monitor the relevant indicators, if there is any adverse reaction after using the drug, it is recommended to stop the drug and consult a doctor promptly.